Pharmafile Logo

Gower Publishing

Sanofi reception

Sanofi gains access to antibody tech with Kymab acquisition

French pharma will receive global rights to phase 2a monoclonal antibody

- PMLiVE

Sandra Carey takes on global president, expert audiences role at McCann Health

Internal promotion sees Carey take the helm of McCann's expert audience practice

- PMLiVE

bluebird bio to separate oncology and rare diseases units

New oncology company will be led by current bluebird bio CEO Nick Leschly

- PMLiVE

Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma

Study will enrol patients who have ‘unmet clinical needs’ after receiving gene therapy

Roche Basel Switzerland

Roche’s flu pill Xofluza gains EU approval

EU approval is based on results from three phase 3 studies

- PMLiVE

New NHS COVID-19 vaccination centres open as cases surge in the UK

NHS is aiming to vaccinate around 15 million people by mid-February

Delphi Technique Virtual Co-creation: A Customer Story

How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints.

Impetus Digital

- PMLiVE

UK approves Moderna’s COVID-19 vaccine, secures another 10 million doses

Total number of doses secured by UK now totals 17 million

- PMLiVE

Pfizer/BioNTech vaccine shown to be effective against new COVID-19 variants

Vaccine tested against variants discovered in the UK and South Africa

- PMLiVE

Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO

Moderna CEO Stéphane Bancel spoke at Oddo BHF event this week

- PMLiVE

Two drugs found to reduce mortality in severe COVID-19 patients

Actemra and Kevzara also improved recovery times among critically ill COVID-19 patients

- PMLiVE

Q&A: Shairose Ebrahim

PME interviews integrated medhealth communication (imc) group's President and CEO

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links